Abstract
The use of mechanical/physical devices for applying mild therapeutic hypothermia is the only proven neuroprotective treatment for survivors of out of hospital cardiac arrest. However, this type of therapy is cumbersome and associated with several side-effects. We investigated the feasibility of using a transient receptor potential vanilloid type 1 (TRPV1) agonist for obtaining drug-induced sustainable mild hypothermia.
| Original language | English |
|---|---|
| Journal | B M C Cardiovascular Disorders |
| Volume | 10 |
| Pages (from-to) | 51 |
| ISSN | 1471-2261 |
| DOIs | |
| Publication status | Published - 1 Jan 2010 |
Fingerprint
Dive into the research topics of 'Drug-induced mild therapeutic hypothermia obtained by administration of a transient receptor potential vanilloid type 1 agonist'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS